AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. KOBAYASHI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Total non-current assets

KOBAYASHI PHARMACEUTICAL CO.,LTD.【JP:4967】

Market cap
¥449.3B
P/E ratio
42.8x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal non-current assets (Million JPY)YoY (%)
Dec 31, 2025126,508+4.64%
Dec 31, 2024120,900+10.77%
Dec 31, 2023109,142+31.60%
Dec 31, 202282,934+17.36%
Dec 31, 202170,664-4.69%
Dec 31, 202074,141+4.89%
Dec 31, 201970,685-6.91%
Dec 31, 201875,930-0.72%
Dec 31, 201776,484+5.37%
Dec 31, 201672,587+5.73%
Mar 31, 201668,650-2.40%
Mar 31, 201570,340

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)